node1 | node2 | node1 accession | node2 accession | node1 annotation | node2 annotation | score |
BCL2 | BCL2L1 | ENSBTAP00000025701 | ENSBTAP00000070613 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | BCL2-like 1 transcript variant 1. | 0.966 |
BCL2 | BID | ENSBTAP00000025701 | ENSBTAP00000040367 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | 0.994 |
BCL2 | BIRC2 | ENSBTAP00000025701 | ENSBTAP00000046955 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Baculoviral IAP repeat containing 2. | 0.599 |
BCL2 | BIRC3 | ENSBTAP00000025701 | ENSBTAP00000034604 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Baculoviral IAP repeat-containing 3. | 0.564 |
BCL2 | BIRC5 | ENSBTAP00000025701 | ENSBTAP00000018046 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Baculoviral IAP repeat-containing protein 5; Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (By similarity). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (By similarity). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with p [...] | 0.675 |
BCL2 | CTSO | ENSBTAP00000025701 | ENSBTAP00000014691 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | Cathepsin O; Belongs to the peptidase C1 family. | 0.900 |
BCL2 | XIAP | ENSBTAP00000025701 | ENSBTAP00000058232 | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | RING-type domain-containing protein. | 0.950 |
BCL2L1 | BCL2 | ENSBTAP00000070613 | ENSBTAP00000025701 | BCL2-like 1 transcript variant 1. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.966 |
BCL2L1 | BID | ENSBTAP00000070613 | ENSBTAP00000040367 | BCL2-like 1 transcript variant 1. | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | 0.983 |
BCL2L1 | BIRC2 | ENSBTAP00000070613 | ENSBTAP00000046955 | BCL2-like 1 transcript variant 1. | Baculoviral IAP repeat containing 2. | 0.692 |
BCL2L1 | BIRC3 | ENSBTAP00000070613 | ENSBTAP00000034604 | BCL2-like 1 transcript variant 1. | Baculoviral IAP repeat-containing 3. | 0.620 |
BCL2L1 | BIRC5 | ENSBTAP00000070613 | ENSBTAP00000018046 | BCL2-like 1 transcript variant 1. | Baculoviral IAP repeat-containing protein 5; Multitasking protein that has dual roles in promoting cell proliferation and preventing apoptosis (By similarity). Component of a chromosome passage protein complex (CPC) which is essential for chromosome alignment and segregation during mitosis and cytokinesis (By similarity). Acts as an important regulator of the localization of this complex; directs CPC movement to different locations from the inner centromere during prometaphase to midbody during cytokinesis and participates in the organization of the center spindle by associating with p [...] | 0.590 |
BCL2L1 | CTSO | ENSBTAP00000070613 | ENSBTAP00000014691 | BCL2-like 1 transcript variant 1. | Cathepsin O; Belongs to the peptidase C1 family. | 0.900 |
BCL2L1 | XIAP | ENSBTAP00000070613 | ENSBTAP00000058232 | BCL2-like 1 transcript variant 1. | RING-type domain-containing protein. | 0.688 |
BID | BCL2 | ENSBTAP00000040367 | ENSBTAP00000025701 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.994 |
BID | BCL2L1 | ENSBTAP00000040367 | ENSBTAP00000070613 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | BCL2-like 1 transcript variant 1. | 0.983 |
BID | CTSO | ENSBTAP00000040367 | ENSBTAP00000014691 | BH3-interacting domain death agonist; Counters the protective effect of Bcl-2. | Cathepsin O; Belongs to the peptidase C1 family. | 0.901 |
BIRC2 | BCL2 | ENSBTAP00000046955 | ENSBTAP00000025701 | Baculoviral IAP repeat containing 2. | Apoptosis regulator Bcl-2; Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1) (By similarity). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (By similarity). | 0.599 |
BIRC2 | BCL2L1 | ENSBTAP00000046955 | ENSBTAP00000070613 | Baculoviral IAP repeat containing 2. | BCL2-like 1 transcript variant 1. | 0.692 |
BIRC2 | BIRC3 | ENSBTAP00000046955 | ENSBTAP00000034604 | Baculoviral IAP repeat containing 2. | Baculoviral IAP repeat-containing 3. | 0.912 |